Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on HT Fen. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel HT-Fen ester synthesis patent CN105753702B offers multi-target metabolic benefits. Scalable route ensures supply continuity for pharma partners.
Patent CN102070426B details an improved synthesis for 3-p-methoxyphenyl-1,2,3,4-tetrahydronaphthalen-1-one, offering enhanced purity and reduced environmental impact for rodenticide manufacturing.